首页> 外文期刊>Journal of Clinical Pathology >Merkel cell carcinoma can be distinguished form metastatic small cell carcinoma using antibodies to ctokeratin 20 and thyrodi transcription factor 1
【24h】

Merkel cell carcinoma can be distinguished form metastatic small cell carcinoma using antibodies to ctokeratin 20 and thyrodi transcription factor 1

机译:默克尔细胞癌可以通过使用角蛋白20和甲状腺癌转录因子1的抗体与转移性小细胞癌区分开

获取原文
获取原文并翻译 | 示例
           

摘要

Aim-To investigate whether immuno- histochemical staining for cytokeratin 20 (CK20) and thyroid transcription factor 1 (TTF-1) is useful in distinguishing Merkel cell carcinomas (MCCs) from metastatic small cell carcinomas (SCCs). Methods-Eleven cases of MCC and 10 of Lung SCC were stained for CK20 and TTF-1. Results-Ten of 11 MCCs stained with the Antibody to CK20. None was positive for TTF-1. No SCC stained with anti-CK20 And all stained strongly with anti-TTF-1. Conclusions-the use of both anti-CK20 And anti-TTF-1 can reliably distinguish Between MCC and metastatic SCC, thus Avoiding the need for a detailed clinical Investigation of patents with MCC in Whom metastatic SCC must be excluded.
机译:目的探讨细胞角蛋白20(CK20)和甲状腺转录因子1(TTF-1)的免疫组织化学染色是否有助于区分默克尔细胞癌(MCC)和转移性小细胞癌(SCC)。方法:对11例MCC和10例肺SCC进行CK20和TTF-1染色。结果-用CK20抗体染色的11个MCC中有十个。 TTF-1均无阳性。 SCC没有被抗CK20染色,并且全部被抗TTF-1染色。结论-同时使用抗CK20和抗TTF-1可以可靠地区分MCC和转移性SCC,从而避免了需要进行MCC转移性SCC专利的详细临床研究的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号